The status of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and the proliferation marker Ki67 are significant predictive factors in breast cancer, playing crucial roles in the clinical decision-making process (Harbeck et al., 2019; Zhang et al., 2021a). This evidence concerns the gene PGR and breast carcinoma.